Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
Patent 5834424 Issued on November 10, 1998. Estimated Expiration Date: 
September 5, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 5, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesFormulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria Bioactive agents and compositions for materials comprising the bioactive agent and a method for treating materials therewith Input circuit and method for holding data in mixed power supply mode Patent #: 5656951 InventorsAssigneeApplicationNo. 924093 filed on 09/05/1997US Classes:514/8, Glycoprotein (carbohydrate containing)424/439, Food or edible as carrier for pharmaceutical424/442, Animal food424/532, Platelet424/657, Boron426/332, Animal flesh426/334, Lacteal derived containing426/335, Biocidal or disinfecting chemical agent426/442, Treatment of food material by addition of material other than water, air, carbon dioxide, nitrogen or inert gases, or mixtures thereof514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/6, Heavy metal containing (e.g., hemoglobin, etc.)514/12, 25 or more peptide repeating units in known peptide chain structure514/21, Produced by or extracted from animal tissue514/192, 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)514/200, 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)530/324, 25 or more amino acid residues in defined sequence530/400, Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.530/832Milk; colostrumExaminersPrimary: Tsang, Cecilia J.Assistant: Harle, Jennifer Attorney, Agent or FirmForeign Patent References
International ClassesA61K 037/02A61K 031/43 A61K 031/545 C07K 013/00 Foreign Application Priority Data1995-07-12 ITAbstractCompositions of lactoferrin, ovotransferrin or serotransferrin in apo or iron-saturated form are provided which have bacterial anti-invasive properties against Streptococcus pyogenes and Staphylococcus aureus. Methods of treatment of epithelial calls and mucosal membranes are described.Other References
Field of SearchHeavy metal containing (e.g., hemoglobin, etc.)Glycoprotein (carbohydrate containing) 25 or more peptide repeating units in known peptide chain structure Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI Produced by or extracted from animal tissue 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) 25 or more amino acid residues in defined sequence Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc. Milk; colostrum Food or edible as carrier for pharmaceutical Animal food Platelet Boron Animal flesh Lacteal derived containing Biocidal or disinfecting chemical agent Treatment of food material by addition of material other than water, air, carbon dioxide, nitrogen or inert gases, or mixtures thereof |
| ||||||||||||||
